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late anesthetic side effects occurred, and satisfaction with 
the anesthetic technique was the same in all groups (97% 
satisfied).
Conclusions Fentanyl 10 or 20 µg as additive to articaine 
for spinal anesthesia prolonged the duration of sensory 
block significantly and similarly. Fentanyl 20 µg was more 
often associated with pruritus than fentanyl 10 µg.
Keywords Day-case spinal anesthesia · Local anesthetic 
articaine · Subarachnoid fentanyl additive · Postoperative 
pruritus
Introduction
Articaine is an amide-type local anesthetic [1, 2] with a 
low degree of toxicity [1, 3, 4]. It has been found useful in 
spinal anesthesia for ambulatory surgery of the lower parts 
of the body [5–7]. Among the doses of articaine studied, 
it seems that in adults 60 mg provides an onset (<5 min) 
and duration (approximately 60 min at the T10-derma-
tomal level) suitable for routine day-surgery of the lower 
extremities.
Low-dose bupivacaine is nowadays popular for day-case 
spinal anesthesia and its analgesic effect can be enforced 
and prolonged by mixing small doses of fentanyl in the 
intrathecal solution [8]. The fentanyl adjunct (10–20 µg) 
does not prolong the duration of motor block [9, 10]. In 
the higher dose range, fentanyl often causes irritating 
pruritus [11]. In the only published study on open ingui-
nal hernia repair performed under spinal anesthesia with 
articaine combined with fentanyl [12], the need for intra-
operative and postoperative analgesics was less with than 
without intrathecal fentanyl, but the duration of the spinal 
block was similar in both groups. This lack of an effect on 
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Objectives Articaine, a popular and rapidly acting local 
anesthetic in dentistry, has been also found to be beneficial 
in ambulatory spinal anesthesia. Analgesia in the intraop-
erative and immediate postoperative period may be further 
improved by adding fentanyl to the local anesthetic solu-
tion for spinal anesthesia. The aim was to evaluate dose-
dependency of analgesia and side effects associated with 
intrathecal fentanyl additive to articaine for spinal anesthe-
sia in knee arthroscopy patients.
Methods In this randomized, observer- and patient-blinded 
study, 90 adult patients scheduled for elective ambulatory 
knee arthroscopy under spinal anesthesia were randomized 
into three groups: plain articaine 60 mg with saline (group 
AF0), articaine 60 mg with fentanyl 10 µg (group AF10) 
or 20 µg (group AF20) in a total volume of 1.9 ml. The 
blinded observer tested the sensory and the motor block, 
and performed telephone interviews on the first and seventh 
postoperative days.
Results The median (IQR) duration of sensory block at 
the dermatomal level of T10 was significantly longer in 
groups AF10, 69 min (56) and AF20, 69 min (45) than in 
group AF0, 41 min (35) (p = 0.013). Motor block dura-
tion was similar in all groups (median 120 min). Group 
AF20 patients experienced pruritus significantly more often 
than patients in the other groups (p = 0.039). No acute or 
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the duration of sensory block by the addition of fentanyl 
prompted us to perform a spinal anesthesia study compa-
rable to those where fentanyl has been shown to prolong 
the sensory block of bupivacaine and lidocaine [9, 10], 
i.e., using a smaller local anesthetic dose and applying it 
in patients undergoing knee arthroscopy. A prolongation 
of articaine spinal anesthesia or analgesia, which other-
wise ends rather quickly, would turn beneficial in cases of 
unexpected increased duration of surgery or when surgery 
is performed by trainees. Our aim was to investigate the 
effects and side effects of two intrathecal fentanyl doses, 10 
and 20 µg, added to 60 mg articaine. We hypothesized that 
the sensory block would be dose-dependently prolonged by 
fentanyl.
Patients and methods
The Ethics Committee §19 (24.4.2009, 47/13/03/02/05, 
and the National Agency for Medicines (25.03.2009 KLnro 
21/2009) approved the study protocol and all patients gave 
their written informed consent. The study was registered in 
the EU clinical trial register (EudraCT 2009-010696-24).
Adult patients [18–75 years old, American Society of 
Anesthesiologists (ASA) class I–II] scheduled for day-
case knee arthroscopy under spinal anesthesia in the day-
surgery center of the university hospital were recruited. 
Exclusion criteria were patient’s refusal, body mass index 
(BMI) >30 kg/m2, pregnancy, low back pain, neuropathy of 
the lower extremities, chronic use of analgesics, self-med-
ication with an analgesic in the morning before surgery, 
problems with communication, and generally accepted 
contraindications to neuraxial anesthesia.
Randomization into three groups was performed using 
a sealed envelope method, stratified to blocks of 30. The 
anesthesiologist performing the intrathecal block prepared 
all the solutions according to the allocation in the operating 
room immediately prior to administration. In group AF0, 
plain articaine (slightly hyperbaric, i.e., density of articaine 
4% at 37 °C 1.0035 g/ml; National Standards Laboratory, 
Centre for Metrology and Accreditation, Espoo, Finland) 
60 mg and 0.9% NaCl 0.4 ml were drawn and mixed in a 
syringe.
In group AF10, plain articaine 60 mg 1.5 ml and fenta-
nyl 10 µg (0.2 ml) and 0.9% NaCl 0.2 ml were drawn and 
mixed in a syringe. In group AF20, plain articaine 60 mg 
1.5 ml and fentanyl 20 µg (0.4 ml) were drawn and mixed 
in a syringe. The final volume of the solutions in each 
group was thereby 1.9 ml and thus the concentration of 
articaine was 32 mg/ml (3.2%). Only the anesthesiologist 
who prepared the local anesthetic solution was aware of 
which anesthetic solution the patient would receive.
Premedication was given approximately 1 h before sur-
gery and consisted of oral etoricoxib 60–120 mg (<60 kg 
60 mg, 60–70 kg 90 mg, >70 kg 120 mg), or alternatively 
oral acetaminophen 0.5–1 g (<65 kg 0.5 g ≥65 kg 1 g) if 
there was a contraindication for etoricoxib. Diazepam 
5–10 mg was given orally if the patient requested a sedative 
when reporting for surgery at the outpatient clinic.
Spinal anesthesia
Before the spinal anesthetic administration, 200–300 ml of 
Ringer’s acetate solution was given intravenously. Intraop-
erative monitoring included ECG, heart rate, and pulse oxi-
metry. Non-invasive arterial blood pressure was recorded in 
the operating room at 5-min intervals.
For spinal anesthetic injection, the patient was placed 
horizontally in the lateral decubitus position with the side 
of intended surgery facing down. After the skin was infil-
trated with 1% lidocaine, the intrathecal puncture was per-
formed in the midline using a 27-gauge pencil-point needle 
at the L3–4 interspace. On obtaining a free flow of cerebro-
spinal fluid and with the needle aperture facing downwards, 
the anesthetic solution was injected at a constant rate of 
approximately 0.1 ml/s. At the end of the injection of the 
total volume, an aspiration was made, and the aspirate 
was reinjected. When the intrathecal injection was started, 
a research assistant who was not aware of this allocation 
entered the operating room.
After injection, the patient was immediately turned 
supine, and the operating table was tilted head-end 10° up 
to prevent from extensive cephalad spread of the block. 
The head-up tilt was retained if the block had spread more 
cephalad than to the T10 dermatome; otherwise the table 
was placed in the horizontal position before the start of 
surgery.
Assessment of the blocks
The dermatomal assessment of the block was always per-
formed by the same research assistant. Dermatomal sen-
sory block was assessed by pin-prick with a 27-gauge 
short bevel needle in caudad to cephalad bilaterally in the 
anterior axillary line at 2-min intervals for 10 min, then at 
5-min intervals until 30 min, and then at 15-min intervals 
until recovery of sensation of the S2 dermatome posteriorly 
at knee joint.
Motor block was assessed on a three-grade scale (grade 
0 = no motor block, grade 1 = reduced ability to bend the 
knee or flex the ankle, grade 2 = complete motor block) at 
5-min intervals for 30 min and, thereafter, at 15-min inter-
vals until the full recovery. During surgery, the motor block 
was only assessed on the non-operative side.
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Supplemental intraoperative medication
Arterial hypotension was treated with ephedrine 5 mg intra-
venously using clinical judgment, or if mean arterial blood 
pressure (MAP) was <60 mmHg. Bradycardia was treated 
with atropine 0.5 mg intravenously at the discretion of the 
attending anesthesiologists, or if the heart rate was <40 
beats/min. Midazolam in 1-mg doses was given for anxi-
ety by the patient’s request or as judged by the attending 
anesthesiologists, and ondansetron 4 mg for nausea and 
vomiting. For painful sensations during surgery, fentanyl 
1 µg/kg IV was given, maximally twice, and thereafter, if 
needed, general anesthesia was administered using propo-
fol, remifentanil, and laryngeal mask airway.
Postoperative evaluation
In the postanesthesia care unit (PACU1 = recovery room), 
the patient’s head-end was tilted up 30° and lower limbs 
elevated. Pain intensity was assessed on a numeric rating 
scale (NRS 0–10: 0 = no pain, 10 = worst imaginable 
pain). The patients received fentanyl 1 µg/kg IV, if NRS 
was ≥4, and the dose was repeated once when necessary. In 
the day-surgery ward (PACU2), patients received 5–10 mg 
oral oxycodone when the intensity of pain on the NRS 
was ≥4. For milder pain (NRS <4) oral acetaminophen was 
given as required. Pruritus, nausea, time to tolerate fluid 
intake by mouth, time to voiding were recorded until dis-
charge. A glass of water or clear fruit juice was offered to 
the patients as soon as they were moved to the PACU2. The 
time when the patient would be ready for discharge was 
also recorded.
The criteria for discharge were stable vital signs, no 
bleeding, ability to drink, no severe pain (NRS 0–3) or 
nausea, ability to ambulate without support, and ability to 
urinate.
Telephone interviews
Telephone interviews were performed by a group-blinded 
research assistant on the first and the seventh postopera-
tive day using standardized questions. Possible side effects, 
complications, pain, nausea, itching, headache (position 
dependent or not), back or leg pain (pain in the gluteal 
region radiating to the legs), as well as the patient’s sat-
isfaction with the anesthetic technique were recorded. In 
case of any signs of a serious complication, the patient was 
called back to the hospital for medical examination and 
treatment.
Power analysis
The primary aim of this study was to compare the effect 
of addition of fentanyl 0, 10, and 20 µg to articaine 60 mg 
on the duration of the spinal analgesia and secondly on 
the occurrence of possible anesthesia-related side effects 
in day-case knee arthroscopy. The power analysis was 
based on the spinal anesthesia study by Chung et al. [13] 
who found that fentanyl 10 µg added to ropivacaine 18 mg 
prolonged sensory analgesia at the T10 dermatome from 
119.3 ± 19.7 to 143.0 ± 34.1 min (mean, SD) (i.e., by 
20%). Assuming a power of 80%, (α 0.05) the sample size 
of 3 × 26 (ANOVA-sample size) was needed to detect a 
statistically significant difference in the median duration of 
sensory block at T10.
Statistics
Statistical analysis was performed with SPSS (version 19.0; 
IBM Corp., Armonk, NY, USA). For continuous normally 
distributed variables, median or mean ± SD were reported 
and tests between the groups were analyzed using one-
way ANOVA with post hoc multiple comparisons (Tukey). 
Repeated measures ANOVA was used for analysis of the 
duration of the sensory and motor block. If the data were 
not normally distributed, Kruskal–Wallis test with pairwise 
post hoc comparison was used, when appropriate. Ordinal 
variables were reported as median (with IQR) and differ-
ences between the groups were analyzed using Mann–
Whitney U test.
Results
One of the 90 randomized patients in group AF0 was 
excluded from the analysis due to protocol violation; he 
had received a combination formulation of acetaminophen 
and codeine for premedication. The remaining 89 patients 
received the allocated intervention. One patient in group 
AF20 required general anesthesia because the sensory 
block was insufficient, and his data are included until the 
induction of general anesthesia (Fig. 1). For premedication, 
84 patients received etoricoxib and five patients received 
acetaminophen. The patients and the surgical characteris-
tics were similar in the three groups (Table 1).
During spinal needle insertion, a paresthetic sensation 
was registered in three group AF0 patients, six group AF10 
patients, and four group AF20 patients, but these patients 
did not report any neurological sequelae afterwards.
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Fig. 1  Flow diagram of 





















-Excluded from the 
final analysis, failed 
block (n=1)
Table 1  Patient characteristics and surgical data for the three groups
Group AF0, articaine 60 mg; group AF10, articaine 60 mg + fentanyl 10 µg; group AF20, articaine 60 mg + fentanyl 20 µg
Data are presented as number (%), mean (range) for age, mean ± SD, or median (IQR). No significant differences between the groups were 
found
AF0 (n = 29) AF10 (n = 30) AF20 (n = 30) p
Age (years) 47 ± 12 46 ± 12 49 ± 13 0.69
Weight (kg) 77 ± 11 76 ± 11 75 ± 13 0.83
Height (cm) 175 ± 9 174 ± 9 171 ± 11 0.35
ASA I/II (n) 21/8 20/10 19/11 0.75
Male/female (n) 16/13 15/15 14/16 0.81
Duration of surgery (min) 32 (20) 38 (15) 32 (16) 0.24
Time from intrathecal injection to the end of surgery (min) 53 (23) 59 (26) 50 (16) 0.10
393J Anesth (2017) 31:389–396 
1 3
Sensory and motor block
Sensory analgesia to the T10 dermatome was reached in 21 
of 29 patients in group AF0, in 21 of 30 in patients group 
AF10 and in 25 of 29 patients in group AF20 in a median 
(IQR) time of 6–8 min (4–6) in all groups. The median 
maximum cephalad spread of sensory block did not differ 
between the three groups (Fig. 2).
Although there was no significant difference in the time 
to two-segment regression of sensory block (Table 2), the 
median (IQR) duration of sensory block at the dermatomal 
level of T10 was significantly longer in group AF10, 69 
(56) min, and group AF20, 69 (45) min, than in group AF0, 
41 (35) min, (p = 0.013) (Table 2).
The motor block was complete (grade 2) in 99% of 
patients at 10 min after the intrathecal injection. All 
patients had a complete motor block 15 min after injection 
on the dependent side, and all but one patient in group AF0 
(who had grade 1) had a complete motor block on the non-
dependent side, too. There were no difference in the dura-
tion of motor block between the groups (Table 2). All the 
patients had a full recovery from motor block 195 min after 
spinal injection.
Intraoperative and in‑hospital postoperative variables 
and medications
During surgery, three patients in group AF10 received fen-
tanyl (0.075, 0.05, and 0.1 mg after 29, 100, and 105 min 
from the intrathecal local anesthetic injection, respec-
tively). Their sensory block level was at dermatome T12, 
L1, and Th12 on the non-dependent side, respectively, 
when intravenous fentanyl was administered. In groups 
AF0 and AF20, intravenous fentanyl was not required 
intraoperatively. None of the patients complained of pain 
from the tourniquet.
The intraoperative hemodynamics was similar in the 
three groups (Table 3). Atropine was given to three, three, 
and four patients, and ephedrine to five, five, and four 
patients in groups AF0, AF10, and AF20, respectively 
(Table 3).
Intraoperative nausea was infrequent in all groups 
(Table 3). One patient in group AF0, with extension of sen-
sory block to dermatome T10, received ondansetron 4 mg 
intravenously for mild nausea. The requirements for sup-
plementary sedation (doses of midazolam 1–2 mg IV) were 
similar in all groups. One patient in both group AF0 and 
group AF10, and two patients in group AF20 experienced 
pruritus intraoperatively, but no medication was required.




T4 ■■■■ ○○○○ ●●●●
T5 ■■ ○○○ ●●●●●●●●
T6 ■ ○○ --●●--
T7 ■■■■ ○○○ ●●●
T8 ■■ --○○○○○-- ●●
T9 --■■■■-- ○○ ●●●
T10 ■■■ ●
T11 ■■■ ○○○○○○ ●●
T12 ■■■■■ ○○ ●●
L1 ○
Fig. 2  Maximum cephalad extent (dermatomes) of sensory block of 
each patient in groups AF0, AF10, AF20. The median level is indi-
cated with a horizontal broken line
Table 2  Data on spinal block and the immediate postoperative (in PACU1 and PACU2) period and on the 1st postoperative day
PACU1 immediate post-anesthesia care unit, recovery room, PACU2 day-surgery ward, 1st POD first postoperative day
Values are expressed as mean ± SD, or median (IQR) and number (%) of patients
* p < 0.05 compared with AF0 and § p < 0.05 compared with AF10
AF0 (n = 29) AF10 (n = 30) AF20 (n = 29) p
Duration of sensory block at higher than T10 (min) 41 (35) 69 (56) 69 (45) 0.013*
Two segment regression of sensory block (min) 60 (45) 60 (30) 60 (30) 0.30
Duration of full motor block (grade 2) (min) 94 ± 15 90 ± 17 89 ± 17 0.68
Patients experiencing pruritus in PACU1, n (%) 1 (3) 3 (10) 7 (24)* 0.046*
Patients experiencing pruritus, 1st POD, n (%) 3/27 (11) 3/28 (10) 9/26 (35)*,§ 0.039
Median time to first voluntary urinary voiding (min) 230 (68) 222 (54) 210 (90) 0.77
Oral oxycodone consumption in PACU2, n (%) 3 (10) 4 (13) 3 (10) 0.95
394 J Anesth (2017) 31:389–396
1 3
In PACU1, postoperative pain at rest was mild in all 
groups (NRS <4); in 24 patients (83%) in group AF0, 29 
patients (97%) in group AF10 and 28 patients (97%) in 
group AF20 there was no pain (NRS 0) or the pain was 
mild (NRS 1–3). No pain at all (NRS 0) was reported by 
11, 14, and 18 patients in groups AF0, AF10 and AF 20, 
respectively (NS). Moderate pain (NRS 4–6) was reported 
by five (17%), one (3%), and one patient (3%) in groups 
AF0, AF10, and AF 20, respectively. None of the patients 
in any group had severe pain (NRS ≥7) in PACU1. The 
need for postoperative oral oxycodone was slightly lower 
in group AF20 than in the other groups (NS) (Table 3). One 
patient in groups AF0 and AF20 received acetaminophen 
orally.
During the stay in PACU1 and PACU2, nausea did not 
occur. Pruritus was more common in Group AF20 than 
in Group AF0 or in Group AF10 (Table 3); the difference 
between Groups AF0 and AF20 was statistically significant 
(p = 0.046) (post hoc analysis). No significant differences 
were found between the groups in time to voiding (Table 2) 
and in the mean time to discharge readiness.
Three patients remained in hospital overnight: one in 
group AF10 because of a surgical complication (hemar-
thron) and another in group AF10 because of inability 
to move safely on crutches. One patient in group AF0 
remained in the hospital overnight because of miss-
ing instructions for immediate postoperative care and 
rehabilitation.
Postoperative interviews
On the first postoperative day, median NRS at rest was 1.8 
in group AF10, and 0 in groups AF0 and AF20. Median 
NRS on movement was 2.0, 2.8, and 1.0 in groups AF0, 
AF10 and AF20, respectively. When moving the oper-
ated leg, the NRS score in group AF10 was significantly 
higher than in group AF0 (p = 0.015) with no other dif-
ferences between the groups. In group AF10, one patient 
temporarily experienced severe pain (NRS = 10) because 
of a surgical complication (hemarthron).
Nine patients in group AF20 reported occurrence of 
pruritus during some period on the 1st POD compared to 
three patients in both groups AF0 and AF10 (p = 0.039) 
(Table 2). The information about pruritus was missing in 
two, two, and three patient interview recordings in groups 
AF0, AF10, and AF20, respectively.
In the 7th postoperative-day interview, 97% of the 
patients in each group responded that they were satisfied 
with their spinal anesthesia. There was one dissatisfied 
patient in each group. One patient in group AF0 suffered 
from a conservatively treated postdural puncture headache 
during the first week, one patient in group AF10 was dissat-
isfied because of an extensive spread of sensory block (T3) 
and associated nausea, and one patient in group AF20 was 
not satisfied because of the sensation of being paralyzed 
and nauseated during surgery. Postoperative voiding diffi-
culties were not encountered in any of the study patients. 
On the 7th postoperative day, pain was absent or negligible. 
Symptoms of neurological sequaleae were not reported.
Discussion
This study showed that adding fentanyl 10 or 20 µg to 
articaine 60 mg for spinal anesthesia prolonged the median 
duration of the sensory block at the T10 dermatomal level 
from 41 min to 69 min as compared to plain articaine. In 
this study, the duration of an analgesic block seemed to be 
insufficient in only one patient, in whom the arthroscopic 
surgery was not finished until 116 min after the intrathecal 
local anesthetic injection. Usually, the sensory block level 
needs to be at least at T10 in order to avoid tourniquet cuff 
pain but knee arthroscopy was performed without pain even 
when in some patients the dermatomal block level was at 
T12. It is probable that this is related to the short duration 
of the operation or to how the knee and the intra-articular 
Table 3  Intraoperative data
Group AF0, articaine 60 mg; group AF10, articaine 60 mg + fentanyl 10 µg; group AF20, articaine 60 mg + fentanyl 20 µg. MAP 0 mean arte-
rial pressure
Values are expressed as mean ± SD and number (%) of patients
Group AF0 (n = 29) AF10 (n = 30) AF20 (n = 29) p value
Intraoperative lowest MAP, mmHg 81 ± 17 83 ± 13 78 ± 14 0.57
Intraoperative lowest heart rate, beats/min 56 ± 11 53 ± 7 54 ± 10 0.46
Intraoperative ephedrine, n (%) 5 (17) 5 (17) 4 (14) 0.93
Intraoperative atropine n (%) 3 (10) 3 (10) 4 (14) 0.88
Intraoperative nausea, n (%) 3 (10) 2 (7) 4 (14) 0.66
Intraoperative midazolam, n (%) 8 (28) 7 (23) 9 (31) 0.80
Patients experiencing pruritus intraoperatively, n (%) 1 (3) 1 (3) 2 (7) 0.76
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tissues are manipulated. In a recent spinal anesthesia study 
in open inguinal herniorrhaphy, the addition of fentanyl 
10 µg to hyperbaric articaine 72 mg significantly reduced 
the need for supplemental intravenous fentanyl intraopera-
tively [12]. Contrary to the present findings, the duration 
of the sensory block at the T10 dermatomal level was not 
affected by intrathecal fentanyl in the study on hernior-
rhaphy patients [12]. The reason for this contrasting result 
is probably mainly due to the fact that in the earlier study 
[12] the dose of the clearly hyperbaric articaine was larger 
than that of the presently used slightly hyperbaric articaine 
(72 vs. 60 mg), and that the spread of the intrathecal solu-
tion was deliberately influenced by protocol-based tilting 
up or down of the operating table. In spite of the relatively 
extensive cephalad spread, the associated arterial blood 
pressure decrease was moderate, and only a few of the 
patients whose maximum sensory block was at or above 
T4 dermatomal level needed intravenous ephedrine. In pre-
vious studies on spinal anesthesia using articaine, higher 
doses (72–108 mg) [7, 14] than that used in the present 
study (60 mg) have resulted in too wide cephalad spread of 
the sensory block and in arterial hypotension.
The quality and duration of motor block were unaf-
fected by the fentanyl additive. In our study, the median 
duration was 120 min, which may be regarded as suitable 
for modern-day surgery and allows early mobilization. In 
earlier studies, the duration of motor block varies to some 
extent in response to different doses; thus, with plain artic-
aine, 84 mg the median motor block duration was 180 min 
[7], with 60 mg 135 min [6] and with 40 mg 105 min [15]. 
In contrast to a typical partial motor block by bupivacaine 
in spinal anesthesia, articaine usually causes a complete 
motor block of the lower extremities [7, 16].
In our organization, “home-readiness” criteria are usu-
ally fulfilled when the patient has walked to the bathroom 
and is able to pass urine, which in our study occurred in a 
median time of 3.5–3.8 h. It is notable that urinary bladder 
catheterizations were not needed in the present study. Even 
in our previous spinal anesthesia studies with articaine in 
open herniorrhaphy patients [7, 12, 16], urinary problems 
have been rare, probably because of the rapid recovery of 
lumbar and sacral spinal nerve function after the use of 
articaine.
Doubling the fentanyl dose did not further improve 
analgesia intraoperatively and in the immediate postopera-
tive period. This is in line with a previous spinal analgesia 
study on the determination of the minimal local analgesic 
dose of bupivacaine in labor where the intrathecal additive 
dose of fentanyl 5 µg provided as good bupivacaine dose-
sparing effect as 15 and 25 µg [17]. However, there was a 
dose-dependent increase in the incidence of pruritus and 
duration of spinal block with increasing fentanyl doses. 
An increase in dose to 20 µg, or above, almost inevitably 
results in disturbing itching [17], while a dose of 50 µg may 
cause respiratory depression [18].
Limitations
The anesthesiologist specialists (either MS or PS) who 
performed the drug mixing, the intrathecal injection, and 
supervised the anesthetic management, were not blinded. 
However, the preparation of the solutions and the intrath-
ecal injection were performed in a prescheduled standard-
ized manner, and the criteria for IV administration of res-
cue fentanyl, atropine, midazolam, and ondansetron, stated 
in the study protocol, were followed. Importantly, the 
research assistant who assessed the spread and durations of 
the blocks, and registered intra- and postoperative events, 
was completely blinded regarding the group allocation.
Conclusions
It is concluded that both fentanyl 10 and 20 µg added to 
plain articaine 60 mg for spinal anesthesia similarly pro-
longed the median duration of sensory block at T 10 der-
matome by almost 70%. The motor block duration was not 
affected by intrathecal fentanyl addition. There was a dose-
dependent effect of fentanyl on the occurrence of pruritus, 
which was most frequent after fentanyl 20 µg. The degree 
of patient satisfaction was high (97% satisfied) and no 
signs of neurotoxicity were observed.
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